Navigation Links
Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018

DUBLIN, August 2, 2013 /PRNewswire/ --

Research and Markets ( has announced the addition of the "Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018" report to their offering.


Radiopharmaceuticals imply the usage of radiation for non-invasive treatment and diagnosis of various diseases. Utilization of these molecules for medical purposes in PET and SPECT imaging has changed the entire algorithm of disease diagnosis. With a rise in the aging population globally, coupled with increasing rate of chronic cardiovascular, oncology and neurology diseases, there is tremendous growth potential in this market, especially in developing nations. Similarly, the use of radiolabeled isotopes with peptides and monoclonal antibodies has opened new boulevards for the growth of the global radiopharmaceuticals market. Many radiopharmaceuticals use technetium-99m (Tc-99m), that has many useful properties of gamma-emitting tracer nuclide.

Radiopharmaceuticals are majorly used to diagnose cancer, tumors, biliary tract blockage, bone diseases, bone marrow diseases, brain diseases, colorectal disease, disorders of iron metabolism and absorption, heart disease, heart muscle damage (infarct), impaired flow of cerebrospinal fluid in the brain, kidney diseases, liver diseases, lung diseases, parathyroid diseases, parathyroid cancer, pernicious anemia, improper absorption of vitamin B12 from intestines, red blood cell diseases, salivary gland diseases, spleen diseases, stomach and intestinal bleeding, stomach problems, tear duct blockage, thyroid diseases, thyroid cancer and urinary bladder diseases.

This may be given to the patient in a number of ways, for e.g. they may be given through the mouth, through injections or placed into the eye or into the bladder. It is a small treatment, which includes use of simple substances containing radioactive isotopes. While treating cancer, these radioactive agents are taken up in the cancerous area to destroy the affected tissues. It works effectively by targeting the areas in the body where the cancer is present. Individuals are advised to intake radiopharmaceuticals only under the direct supervision of a doctor.

This report analyses the global scenario of the radiopharmaceuticals market, discussing detailed overview and market figures. The research report analyses the industry growth rate, industry capacity, and industry structure. The report analyses the historical data, and forecasts the radiopharmaceuticals market size, production forecasts along with key factors driving and restraining the market.

Key Topics Covered:

Chapter 1 Introduction
Chapter 2 Executive Summary
Chapter 3 Global Radiopharmaceuticals Market Overview
Chapter 4 Market Definition & Supply Chain Analysis
Chapter 5 Global Radiopharmaceutical Generators Market
Chapter 6 Global Radiopharmaceuticals Market, By End-User Groups
Chapter 7 Global Radiopharmaceuticals Market, By Applications
Chapter 8 Global Radiopharmaceuticals Market, By Geography
Chapter 9 Market Share Analysis By Key Players
Chapter 10 Recommendations
Chapter 11 Company Profiles

Companies Mentioned

- Cardinal Health Inc.
- Covidien Plc
- GE Healthcare
- IBA Group
- Lantheus Medical Imaging
- Monrol Nuclear Products, Inc.
- Nordion, Inc.
- NTP Radioisotopes (Pty) Ltd
- Polatom
- Positron Corporation
- Siemens Healthcare

For more information visit

Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. ImaginAb and Singapore Radiopharmaceuticals Sign Master Service Agreement
2. Radiopharmaceuticals and Contrast Media: Frost & Sullivan Predicts Market Growth in Europe
3. Global Radiopharmaceuticals Market Is Expected to Reach USD 12.2 Billion in 2018: Transparency Market Research
4. European Nuclear Medicine / Radiopharmaceuticals Market Worth by Reach $1.6 Billion by 2017
5. European Nuclear Medicine / Radiopharmaceuticals Market - Global Trends & Forecasts to 2017
6. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Market Worth $825 Million by 2017
7. Piramal Imaging Highlights New Data for Florbetaben and Other Investigational Radiopharmaceuticals at SNMMI 2013
8. Rapid Fire Marketing Funds Development of Second Generation Vapor Inhaler
9. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
10. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
11. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016 Revolutionary ... Oticon , industry leaders in advanced audiology ... of Oticon Opn ™, the world,s first internet ... possibilities for IoT devices.      (Photo: ... introduces a number of ,world firsts,: , ...
(Date:6/23/2016)... MEDIA, Pa. , June 23, 2016 ... treatments in an outpatient dialysis facility.  Treatments are usually ... to 6 hours per visit, including travel time, equipment ... on a patient, but especially grueling for patients who ... residents of a skilled nursing and rehabilitation centers for ...
(Date:6/23/2016)... June 23, 2016  Experian Health, the ... transforming the patient payment and care experience, ... new products and services that will enhance ... cycle offerings. These award-winning solutions will enable ... remain compliant in an ever-changing environment and ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, ... Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments in ... the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
Breaking Medicine News(10 mins):